DocCheck Valuation
| AJ91 Stock | EUR 8.85 0.20 2.21% |
At this time, the firm appears to be overvalued. DocCheck AG shows a prevailing Real Value of €7.65 per share. The current price of the firm is €8.85. Our model computes the value of DocCheck AG from reviewing the firm fundamentals such as Current Valuation of 57.74 M, profit margin of 0.10 %, and Operating Margin of 0.15 % as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.
Overvalued
Today
Please note that DocCheck's price fluctuation is not too volatile at this time. Calculation of the real value of DocCheck AG is based on 3 months time horizon. Increasing DocCheck's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for DocCheck AG is useful when determining the fair value of the DocCheck stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of DocCheck. Since DocCheck is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DocCheck Stock. However, DocCheck's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.85 | Real 7.65 | Hype 8.85 |
The real value of DocCheck Stock, also known as its intrinsic value, is the underlying worth of DocCheck AG Company, which is reflected in its stock price. It is based on DocCheck's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of DocCheck's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence DocCheck's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of DocCheck AG helps investors to forecast how DocCheck stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DocCheck more accurately as focusing exclusively on DocCheck's fundamentals will not take into account other important factors: DocCheck Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining DocCheck's current stock value. Our valuation model uses many indicators to compare DocCheck value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DocCheck competition to find correlations between indicators driving DocCheck's intrinsic value. More Info.DocCheck AG is number one stock in price to earning category among related companies. It is number one stock in price to book category among related companies fabricating about 0.11 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for DocCheck AG is roughly 9.15 . Comparative valuation analysis is a catch-all model that can be used if you cannot value DocCheck by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for DocCheck's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DocCheck's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates DocCheck's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in DocCheck and how it compares across the competition.
About DocCheck Valuation
The stock valuation mechanism determines the current worth of DocCheck AG on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of DocCheck AG. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of DocCheck AG based exclusively on its fundamental and basic technical indicators. By analyzing DocCheck's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of DocCheck's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of DocCheck. We calculate exposure to DocCheck's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to DocCheck's related companies.DocCheck AG, through its subsidiaries, operates B2B portal for medical professionals in Europe. In addition, the company develops and implements communication strategies at the Cologne site based on media for the healthcare and B2B markets. DOCCHECK operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 248 people.
8 Steps to conduct DocCheck's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates DocCheck's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct DocCheck's valuation analysis, follow these 8 steps:- Gather financial information: Obtain DocCheck's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine DocCheck's revenue streams: Identify DocCheck's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research DocCheck's industry and market trends, including the size of the market, growth rate, and competition.
- Establish DocCheck's growth potential: Evaluate DocCheck's management, business model, and growth potential.
- Determine DocCheck's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate DocCheck's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in DocCheck AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the DocCheck AG information on this page should be used as a complementary analysis to other DocCheck's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for DocCheck Stock analysis
When running DocCheck's price analysis, check to measure DocCheck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DocCheck is operating at the current time. Most of DocCheck's value examination focuses on studying past and present price action to predict the probability of DocCheck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DocCheck's price. Additionally, you may evaluate how the addition of DocCheck to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Global Correlations Find global opportunities by holding instruments from different markets |